Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTHAR for Temperature-Induced Conduction Block in MS
NCT00854750Phase 4Terminated
- Sponsor
- The Frohman Foundation
- Start
- May 2009
- Primary completion
- May 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of repository corticotropin injection in multiple sclerosis (MS) (4 arms), sponsored by The Frohman Foundation. Primary endpoint: Protection against worsening of INO and its effect on reading with body heating. Started May 2009; status: terminated.
02
Drugs
repository corticotropin injection
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00854750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00854750.